Salene M W Jones1, Katherine A Guthrie2, Susan D Reed3, Carol A Landis4, Barbara Sternfeld5, Andrea Z LaCroix6, Andrea Dunn5, Robert L Burr4, Katherine M Newton7. 1. Group Health Research Institute, 1730 Minor Ave, Seattle, WA 98101, United States. Electronic address: wu.582@osu.edu. 2. Fred Hutchinson Cancer Research Center, Seattle, WA, United States. 3. Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States. 4. School of Nursing, University of Washington, Seattle, WA, United States. 5. Kaiser Permanente Division of Research, Oakland, CA, United States. 6. University of California San Diego, San Diego, CA, United States. 7. Group Health Research Institute, 1730 Minor Ave, Seattle, WA 98101, United States.
Abstract
OBJECTIVES: Heart rate variability (HRV) reflects the integration of the parasympathetic nervous system with the rest of the body. Studies on the effects of yoga and exercise on HRV have been mixed but suggest that exercise increases HRV. We conducted a secondary analysis of the effect of yoga and exercise on HRV based on a randomized clinical trial of treatments for vasomotor symptoms in peri/post-menopausal women. DESIGN: Randomized clinical trial of behavioral interventions in women with vasomotor symptoms (n=335), 40-62 years old from three clinical study sites. INTERVENTIONS: 12-weeks of a yoga program, designed specifically for mid-life women, or a supervised aerobic exercise-training program with specific intensity and energy expenditure goals, compared to a usual activity group. MAIN OUTCOME MEASURES: Time and frequency domain HRV measured at baseline and at 12 weeks for 15min using Holter monitors. RESULTS: Women had a median of 7.6 vasomotor symptoms per 24h. Time and frequency domain HRV measures did not change significantly in either of the intervention groups compared to the change in the usual activity group. HRV results did not differ when the analyses were restricted to post-menopausal women. CONCLUSIONS: Although yoga and exercise have been shown to increase parasympathetic-mediated HRV in other populations, neither intervention increased HRV in middle-aged women with vasomotor symptoms. Mixed results in previous research may be due to sample differences. Yoga and exercise likely improve short-term health in middle-aged women through mechanisms other than HRV.
OBJECTIVES: Heart rate variability (HRV) reflects the integration of the parasympathetic nervous system with the rest of the body. Studies on the effects of yoga and exercise on HRV have been mixed but suggest that exercise increases HRV. We conducted a secondary analysis of the effect of yoga and exercise on HRV based on a randomized clinical trial of treatments for vasomotor symptoms in peri/post-menopausal women. DESIGN: Randomized clinical trial of behavioral interventions in women with vasomotor symptoms (n=335), 40-62 years old from three clinical study sites. INTERVENTIONS: 12-weeks of a yoga program, designed specifically for mid-life women, or a supervised aerobic exercise-training program with specific intensity and energy expenditure goals, compared to a usual activity group. MAIN OUTCOME MEASURES: Time and frequency domain HRV measured at baseline and at 12 weeks for 15min using Holter monitors. RESULTS: Women had a median of 7.6 vasomotor symptoms per 24h. Time and frequency domain HRV measures did not change significantly in either of the intervention groups compared to the change in the usual activity group. HRV results did not differ when the analyses were restricted to post-menopausal women. CONCLUSIONS: Although yoga and exercise have been shown to increase parasympathetic-mediated HRV in other populations, neither intervention increased HRV in middle-aged women with vasomotor symptoms. Mixed results in previous research may be due to sample differences. Yoga and exercise likely improve short-term health in middle-aged women through mechanisms other than HRV.
Authors: Elizabeth Tharion; Prasanna Samuel; R Rajalakshmi; G Gnanasenthil; Rajam Krishna Subramanian Journal: Indian J Physiol Pharmacol Date: 2012 Jan-Mar
Authors: Barbara Sternfeld; Katherine A Guthrie; Kristine E Ensrud; Andrea Z LaCroix; Joseph C Larson; Andrea L Dunn; Garnet L Anderson; Rebecca A Seguin; Janet S Carpenter; Katherine M Newton; Susan D Reed; Ellen W Freeman; Lee S Cohen; Hadine Joffe; Melanie Roberts; Bette J Caan Journal: Menopause Date: 2014-04 Impact factor: 3.310
Authors: Susan D Reed; Andrea Z LaCroix; Garnet L Anderson; Kristine E Ensrud; Bette Caan; Janet S Carpenter; Lee Cohen; Susan J Diem; Ellen W Freeman; Hadine Joffe; Joseph C Larson; Susan M McCurry; Caroline M Mitchell; Katherine M Newton; Barbara Sternfeld; Katherine A Guthrie Journal: Menopause Date: 2020-04 Impact factor: 2.953
Authors: Liye Zou; Jeffer Eidi Sasaki; Gao-Xia Wei; Tao Huang; Albert S Yeung; Octávio Barbosa Neto; Kevin W Chen; Stanley Sai-Chuen Hui Journal: J Clin Med Date: 2018-10-31 Impact factor: 4.241